glioblastoma

Brain cancer drugmaker raises another $3.5 million

The market for newly diagnosed brain cancer therapies is in serious need of new innovation – few therapies exist on the market for this indication. Diffusion Pharmaceuticals, a 13-year-old Virginia biotech in the midst of mid-stage clinical trials for brain cancer, just raised about $3.5 million, according to a regulatory filing. The company’s most advanced drug […]